Ubs Group Ag Rx Sight, Inc. Transaction History
Ubs Group Ag
- $611 Billion
- Q3 2025
A detailed history of Ubs Group Ag transactions in Rx Sight, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 735,170 shares of RXST stock, worth $7.15 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
735,170
Previous 259,775
183.0%
Holding current value
$7.15 Million
Previous $3.38 Million
95.71%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RXST
# of Institutions
168Shares Held
32.2MCall Options Held
64.6KPut Options Held
62.9K-
Black Rock Inc. New York, NY2.4MShares$23.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$21.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$20.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.83MShares$17.8 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.75MShares$17.1 Million0.02% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $269M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...